FHTX
NASDAQ
US
Foghorn Therapeutics Inc. - Common Stock
$4.93
▲ +$0.03
(+0.61%)
Vol 88K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$305.4M
ROE
-301.6%
Margin
-294.2%
D/E
0.00
Beta
3.01
52W
$3–$7
Wall Street Consensus
16 analysts · Apr 20267
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
93.8%
Buy Rating
Price Chart
Similar Stocks
PALI
Palisade Bio Inc
$350.2M
CLYM
Climb Bio Inc
$272.7M
RZLT
Rezolute Inc
$218.8M
OVID
Ovid Therapeutics Inc
$116.1M
ORGO
Organogenesis Holdings Inc
P/E 654.1
$657.4M
NBP
NovaBridge Biosciences
$458.9M
AVXL
Anavex Life Sciences Corp
$318.1M
TARA
Protara Therapeutics Inc
$275.2M
CCCC
C4 Therapeutics Inc
$185.1M
Earnings
Beat rate: 75.0%
Next Report
May 12, 2026
EPS Estimate: $-0.30
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.30 | — | — |
| Dec 2025 | $-0.25 | $-0.34 | $-0.09 |
| Sep 2025 | $-0.34 | $-0.25 | +$0.09 |
| Jun 2025 | $-0.37 | $-0.28 | +$0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -301.6% | -301.6% | -301.6% | -301.6% | -301.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -237.3% | -311.9% | -311.9% | -311.9% | -294.2% | -294.2% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.62 | 2.62 | 2.62 | 2.62 | 2.16 | 2.16 |
Key Ratios
ROA (TTM)
-29.6%
P/S (TTM)
12.46
P/B
2667.0
EPS (TTM)
$-1.15
CF/Share
$-2.38
Rev Growth 3Y
+157.8%
52W High
$6.79
52W Low
$2.94
$2.94
52-Week Range
$6.79
How does FHTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
FHTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
12.5
▼
3%
below
peers
(12.9)
vs Peers
vs Industry
Fair value
P/B ratio
2667.0
▲
108313%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
FHTX profitability vs Biotechnology peers
ROE
-301.6%
▼
348%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-294.2%
▼
3%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-29.6%
▲
37%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
FHTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.2
▼
51%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
3.0
▲
211%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
FHTX fundamentals radar
FHTX
Peer median
Industry
FHTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
FHTX vs peers: key metrics
Latest News
No related news yet